发明人马晓峰,胡光,杨光. "Method for the Synthesis of Entecavir Impurity" [P]. 中国发明专利, 专利号 CN 113646601 B, 授权公告日 2016-02-06.
Mueller T, O'Brien P Q, Yamamoto T. "A Process for Preparing High-Purity Entecavir Impurity" [P]. US Patent, US 9727237 B2, 2021-12-16.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 恩替卡韦杂质31 in Pharmaceutical Formulations". Phytochemistry, 2022, 1009, (3), 362-387.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩替卡韦杂质31 as an Impurity". Sci. Total Environ., 2017, 2075, 5571-5600.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Entecavir Impurity Using HRMS and NMR". Molecules, 2012, 2192, (4), 9756-9772.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 恩替卡韦杂质31 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2011, 1760, (10), 1903-1930.